MOTS-c is a mitochondrial-derived hexadecapeptide (16 amino acids, MT-RNR1 encoded), available in 10mg, 20mg, or 40mg lyophilized vials
Therefore, if you have headaches that arent improving and notice any of these other symptoms, it may be time to talk to your doctor about whether IgG4-RD could be a possibility
He also pointed out the higher dose led to a greater incidence of dysasesthesia a condition characterized by abnormal pain sensations which he said as far as I am aware are a relatively new adverse event with this class of compounds and deserves further investigation, including further evaluation of nerve conduction studies to ensure that there is no adverse effect on peripheral sensory nerves. Camilleri noted evidence that GLP-1 receptors are present on peripheral sensory nerves as additional justification to thoroughly evaluate safety data related to sensory nerve function
Theres no regulation around compounded versions of semaglutide, so you dont know if youre getting the right potency of the medication or not, she cautions
It is effective even in models of nerve damage
Not to mention ongoing shortages of GLP-1s are making it hard for patients to start and continue taking them as prescribed